Who
Andrew T. Sheehan
Director
Company insider
Files Form 4 as: Director, Yext; Director, QuinStreet; 10% owner, Threshold Pharmaceuticals; 10% owner, Mattersight; 10% owner, Cardica; 10% owner, Corcept Therapeutics; 10% owner, Data Domain; Director, Aviza Technology.
In numbers
- Trades disclosed
- 220
- Buys
- 57
- Sells
- 18
- Bought
- $21.7M
- Sold
- $18.7M
- Companies
- 8
- Companies where not an officer
- 8
- First trade
- 6 Feb 2007
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | YEXT YextPayments & Processors | SEC FORM 4 Code A | —43,209 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | YEXT YextPayments & Processors | SEC FORM 4 Code A | —43,209 at $0.00 | filing |
| 30 Oct 2025filed 3 Nov 2025 | QNST QuinStreetBusiness Services | SEC FORM 4 Code A | —9,938 at $0.00 | filing |
| 30 Oct 2025filed 3 Nov 2025 | QNST QuinStreetBusiness Services | SEC FORM 4 Code G | —7,732 at $0.00 | filing |
| 30 Oct 2025filed 3 Nov 2025 | QNST QuinStreetBusiness Services | SEC FORM 4 Code G | —7,732 at $0.00 | filing |
| 11 Jun 2025filed 12 Jun 2025 | YEXT YextPayments & Processors | SEC FORM 4 Code A | —27,131 at $0.00 | filing |
| 22 Nov 2024filed 13 Aug 2025 | QNST QuinStreetBusiness Services | SEC FORM 4 Code G | —47,286 at $0.00 | filing |
| 22 Nov 2024filed 13 Aug 2025 | QNST QuinStreetBusiness Services | SEC FORM 4 Code G | —47,286 at $0.00 | filing |
| 20 Nov 2024filed 22 Nov 2024 | QNST QuinStreetBusiness Services | SEC FORM 4 Sold | $215K10,000 at $21.50 | filing |
| 13 Nov 2024filed 14 Nov 2024 | QNST QuinStreetBusiness Services | SEC FORM 4 Code G | —6,734 at $0.00 | filing |
| 31 Oct 2024filed 4 Nov 2024 | QNST QuinStreetBusiness Services | SEC FORM 4 Code A | —6,904 at $0.00 | filing |
| 12 Jun 2024filed 13 Jun 2024 | YEXT YextPayments & Processors | SEC FORM 4 Code A | —31,250 | filing |
| 15 Nov 2023filed 16 Nov 2023 | QNST QuinStreetoption or derivative · Business Services | SEC FORM 4 Code M | —50,000 at $0.00 | filing |
| 15 Nov 2023filed 16 Nov 2023 | QNST QuinStreetBusiness Services | SEC FORM 4 Code M | $170K50,000 at $3.40 | filing |
| 15 Nov 2023filed 16 Nov 2023 | QNST QuinStreetBusiness Services | SEC FORM 4 Sold | $572K50,000 at $11.44 | filing |
| 27 Oct 2023filed 31 Oct 2023 | QNST QuinStreetBusiness Services | SEC FORM 4 Code A | —14,471 at $0.00 | filing |
| 13 Jun 2023filed 15 Jun 2023 | YEXT YextPayments & Processors | SEC FORM 4 Code A | —20,588 at $0.00 | filing |
| 31 Oct 2022filed 2 Nov 2022 | QNST QuinStreetBusiness Services | SEC FORM 4 Code A | —12,708 at $0.00 | filing |
| 14 Jun 2022filed 15 Jun 2022 | YEXT YextPayments & Processors | SEC FORM 4 Code A | —25,996 at $0.00 | filing |
| 25 Oct 2021filed 27 Oct 2021 | QNST QuinStreetBusiness Services | SEC FORM 4 Code A | —9,938 at $0.00 | filing |
News
Corcept Therapeutics (NASDAQ:CORT) Stock Falls 14.5% – Should You Sell?CORT · themarketsdaily.com · 23 Oct 2026Corcept Therapeutics (NASDAQ:CORT) vs. Ovid Therapeutics (NASDAQ:OVID) Head-To-Head ContrastCORT · themarketsdaily.com · 15 Oct 2026Contrasting QuinStreet (NASDAQ:QNST) and Trivago N.V. ADS (NASDAQ:TRVG)QNST · dailypolitical.com · 15 Oct 2026
0 headlines in the last 90 days name Andrew T. Sheehan; 3 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.